Skip to main content
Ipca Laboratories Limited (NSE:IPCALAB)
India flag India · Delayed Price · Currency is INR
1,528.90
+6.10 (0.40%)
At close: Feb 27, 2026

Ipca Laboratories Revenue

Ipca Laboratories had revenue of 23.93B INR in the quarter ending December 31, 2025, with 6.55% growth. This brings the company's revenue in the last twelve months to 95.06B, up 8.93% year-over-year. In the fiscal year ending March 31, 2025, Ipca Laboratories had annual revenue of 89.41B with 16.03% growth.

Revenue (ttm)
95.06B
Revenue Growth
+8.93%
P/S Ratio
4.08
Revenue / Employee
5.67M
Employees
16,778
Market Cap
387.89B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Mar 31, 202589.41B12.35B16.03%
Mar 31, 202477.06B14.58B23.33%
Mar 31, 202362.48B4.18B7.16%
Mar 31, 202258.31B4.10B7.56%
Mar 31, 202154.21B7.71B16.58%
Mar 31, 2020 Pro Pro Pro
Mar 31, 2019 Pro Pro Pro
Mar 31, 2018 Pro Pro Pro
Mar 31, 2017 Pro Pro Pro
Mar 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Ajanta Pharma 52.02B
Gland Pharma 61.13B
Emcure Pharmaceuticals 88.50B
Laurus Labs 67.22B
Glenmark Pharmaceuticals 165.10B
Wockhardt 31.74B
Alkem Laboratories 142.53B
Piramal Pharma 88.71B
Revenue Rankings

Ipca Laboratories News

More News